Source: http://www.kslegislature.org/li_2016/b2015_16/statute/074_000_0000_chapter/074_099b_0000_article/074_099b_0034_section/074_099b_0034_k/
Timestamp: 2019-04-26 04:53:40+00:00

Document:
(b) Distributions from the bioscience development and investment fund shall be for the exclusive benefit of the authority, under the control of the board and used to fulfill the purpose, powers and duties of the authority pursuant to the provisions of K.S.A. 2016 Supp. 74-99b01 et seq., and amendments thereto.
(2) (A) For fiscal year 2016, fiscal year 2017 and fiscal year 2018, the first $1,000,000 that the secretary of revenue certifies to the state treasurer of the annual 95% of withholding above the base, upon Kansas wages paid by bioscience employees, shall be transferred by the director of accounts and reports from the state general fund to the following: The center of innovation for biomaterials in orthopaedic research – Wichita state university fund.
(3) (A) For fiscal year 2016, fiscal year 2017 and fiscal year 2018, the next $5,000,000 that the secretary of revenue certifies to the state treasurer of the annual 95% of withholding above the base, upon Kansas wages paid by bioscience employees above the first $1,000,000 certified pursuant to subsection (d)(2)(A), shall be transferred by the director of accounts and reports from the state general fund to the following: The national bio agro-defense facility fund at Kansas state university.
(h) During the fiscal year ending June 30, 2016, the aggregate amount that is directed to be transferred from the state general fund to the bioscience development and investment fund pursuant to subsection (d)(1) plus interest earnings pursuant to subsection (d)(1) shall not exceed $6,997,663 for such fiscal year.
(i) During the fiscal year ending June 30, 2017, the aggregate amount that is directed to be transferred from the state general fund to the bioscience development and investment fund pursuant to subsection (d)(1) plus interest earnings pursuant to subsection (d)(1) shall not exceed $6,000,000 for such fiscal year.
(j) During the fiscal year ending June 30, 2018, the aggregate amount that is directed to be transferred from the state general fund to the bioscience development and investment fund pursuant to subsection (d)(1) plus interest earnings pursuant to subsection (d)(1) shall not exceed $6,000,000 for such fiscal year.
History: L. 2004, ch. 112, § 21; L. 2005, ch. 75, § 2; L. 2011, ch. 118, § 191; L. 2012, ch. 175, § 156; L. 2013, ch. 136, § 268; L. 2014, ch. 142, § 113; L. 2015, ch. 104, § 239; L. 2016, ch. 12, § 109; L. 2016, ch. 111, § 53; June 9.

References: § 21
 § 2
 § 191
 § 156
 § 268
 § 113
 § 239
 § 109
 § 53